Lapatax: a phase I study of neoadjuvant lapatinib combined with docetaxel in Her2/neu overexpressing breast cancer (BC). EORTC protocol 10054 : poster 5112

---

Autoria(s): Bonnefoi H.; Zaman K.; Nobahar M.; Koch K.M.; Pierga J.Y.; Campone M.; Brain E.; Bartlett J.; Marreaud S.; Bogaerts J.; Cameron D.

Data(s)	2008
Identificador	http://serval.unil.ch/?id=serval:BIB_7E2B4ED02520
Idioma(s)	en
Fonte	31st Annual San Antonio Breast Cancer Symposium (SABCS)
Tipo	info:eu-repo/semantics/conferenceObject inproceedings